Announcements Trials
Browse Landscape

Phase

Phase 2 27Phase 3 12Phase NA 8Phase 4 4Phase 2/3 4Phase 1/2 4Phase 1 2

Status

Completed 17Terminated 5Unknown 4Withdrawn 3Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 3

Conditions

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients. 1Myofibroma 1Locally Advanced Breast Cancer 1Breast Neoplasms 1

Interventions

Metformin 16Cyclophosphamide 15Drug Therapy 14Dexamethasone 14Cisplatin 14Cytarabine 11Gemcitabine 10Radiotherapy 9Carboplatin 9Vincristine 8Paclitaxel 8Oxaliplatin 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Letrozole × Clear all
NCT05809024 2023-04-12

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Shandong Cancer Hospital and Institute

Phase 4 Unknown
100 enrolled
Breast

Locally Advanced Breast Cancer

NCT04364581 2020-04-28

Endometrial Preparation by Short Course of Letrozole Before Hysteroscopic Removal of Endocavitary Lesions

Mansoura University

Phase 4 Unknown
30 enrolled

Myofibroma

NCT01908556 2013-07-25

PreFace

Institut fuer Frauengesundheit

Phase 4 Unknown
3,545 enrolled
Breast

is to Identify Biomarkers That Could Predict the Efficacy of an Adjuvant Letrozol Treatment in Postmenopausal Breast Cancer Patients.

NCT01072318 2010-02-22

LEXTOP

Korean Breast Cancer Study Group

Phase 4 Unknown
495 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡